Benzinga | Mar 25, 2021 04:09PM EDT

ENDRA Life Sciences Q4 EPS $(0.10) Beats $(0.14) Estimate

ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.14) by 28.57 percent. This is a 91.67 percent increase over losses of $(1.20) per share from the same period last year.